1-3 of 3
Shiro Kubonishi
Close
Sort by
Journal Articles

Safety, Efficacy, and Pharmacokinetic Profiles of Intravenous Rigosertib in Japanese Patients with Recurrent/Relapsed or Refractory Myelodysplastic Syndromes: A Multicenter, Open-Label Phase I Clinical Study

Michinori Ogura, Yukio Kobayashi, MD PhD, Shiro Kubonishi, MD PhD, Michihiro Hidaka, MD PhD, Toshiki Uchida, MD PhD, Yasushi Takamatsu, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5549.
https://doi.org/10.1182/blood.V128.22.5549.5549
Published: 2016
Journal Articles

Unrelated Cord Blood Transplantation after Nonmyeloablative Conditioning: Single Institutional Retrospective Comparison with Bone Marrow or Peripheral Blood Stem-Cell Transplants.

Koichiro Kobayashi, MD, Yoshinobu Maeda, MD, Hisakazu Nishimori, MD, Haruko Sugiyama, MD, Kazutoshi Aoyama, MD, Tomoko Kikuchi, MD, Noriko Namba, MD, Shiro Kubonishi, MD, Masami Niiya, MD, Katsuji Shinagawa, MD, Kazuma Ikeda, MD, Mitsune Tanimoto, MD
Journal: Blood
Blood (2008) 112 (11): 1967.
https://doi.org/10.1182/blood.V112.11.1967.1967
Published: 2008
Journal Articles

Sulfated Colominic Acid Enhances CXCR4 Function and Promotes Hematopoietic Stem /Progenitor Egress from Bone Marrow.

Shiro Kubonishi, MD, Yoshio Katayama, MD, PhD, Shinya Yamaguchi, Hirokazu Tamamura, PhD, Nobutaka Fujii, PhD, Takeshi Watanabe, MD, PhD, Fernando Arenzana-Seisdedos, MD, Kazuma Ikeda, MD, PhD, Mitsune Tanimoto, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 1390.
https://doi.org/10.1182/blood.V106.11.1390.1390
Published: 2005